dc.contributor.author | Karaca, Feryal | |
dc.contributor.author | Karabulut, Senem | |
dc.contributor.author | Ozkara, Irem Oner | |
dc.contributor.author | Tas, Faruk | |
dc.contributor.author | Bilgin, Elif | |
dc.contributor.author | Afsar, Cigdem Usul | |
dc.contributor.author | Karabulut, Mehmet | |
dc.contributor.author | Alis, Halil | |
dc.contributor.author | Binboga, Sinan | |
dc.date.accessioned | 2021-03-03T11:56:16Z | |
dc.date.available | 2021-03-03T11:56:16Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Karabulut S., Afsar C. U. , Karabulut M., Alis H., Binboga S., Ozkara I. O. , Karaca F., Bilgin E., Tas F., "CIRCULATING MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (MIP1-A) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PATIENTS WITH PANCREATIC ADENOCARCINOMA", ACTA MEDICA MEDITERRANEA, cilt.32, sa.4, ss.1035-1040, 2016 | |
dc.identifier.issn | 0393-6384 | |
dc.identifier.other | av_2aec9c22-1d28-499e-9487-b86fbaffe533 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/33600 | |
dc.identifier.uri | https://doi.org/10.19193/0393-6384_2016_4_128 | |
dc.description.abstract | Introduction: Pancreatic cancer is the fourth leading cause of cancer-related death in the United States among both men and women. Macrophage inflammatory protein-1 alpha [MIP-1 alpha/CC-chemokine ligand 3 (CCL3)] is a small chemotactic protein detected in several kinds of tumor tissue samples and functions as a key regulator of cancer progression. This study aimed to investigate the serum MIP-1 alpha/CCL3 levels in pacreatic adenocarcinoma (PA). | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.subject | Temel Tıp Bilimleri | |
dc.title | CIRCULATING MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (MIP1-A) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PATIENTS WITH PANCREATIC ADENOCARCINOMA | |
dc.type | Makale | |
dc.relation.journal | ACTA MEDICA MEDITERRANEA | |
dc.contributor.department | Istanbul Training & Research Hospital , , | |
dc.identifier.volume | 32 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 1035 | |
dc.identifier.endpage | 1040 | |
dc.contributor.firstauthorID | 229009 | |